De-risking preclinical drug development: simultaneous assessment of efficacy and toxicity


This video discusses a PBMC humanized mouse model that measures differential cytokine release profiles for individual human donors after drug treatment and enables the assessment of treatment efficacy against specific tumor cells in vivo.

View More
View Less

Share this video